...
首页> 外文期刊>Bioorganic and medicinal chemistry >2,4-Diamino-5-methyl-6-substituted arylthio-furo(2,3-d)pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.
【24h】

2,4-Diamino-5-methyl-6-substituted arylthio-furo(2,3-d)pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.

机译:2,4-二氨基-5-甲基-6-取代的芳硫基-呋喃(2,3-d)嘧啶类化合物是新型的经典和非经典抗叶酸药,它们是潜在的双重胸苷酸合酶和二氢叶酸还原酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A novel classical antifolate N-{4-[(2,4-diamino-5-methyl-furo[2,3-d]pyrimidin-6-yl)thio]-benzoyl}-l-glutamic acid 5 and 11 nonclassical antifolates 6-16 were designed, synthesized, and evaluated as inhibitors of dihydrofolate reductase (DHFR) and thymidylate synthase (TS). The nonclassical compounds 6-16 were synthesized from 20 via oxidative addition of substituted thiophenols using iodine. Peptide coupling of the intermediate acid 21 followed by saponification gave the classical analog 5. Compound 5 is the first example, to our knowledge, of a 2,4-diamino furo[2,3-d]pyrimidine classical antifolate that has inhibitory activity against both human DHFR and human TS. The classical analog 5 was a nanomolar inhibitor and remarkably selective inhibitor of Pneumocystis carinii DHFR and Mycobacterium avium DHFR at 263-fold and 2107-fold, respectively, compared to mammalian DHFR. The nonclassical analogs 6-16 were moderately potent against pathogen DHFR or TS. This study shows that the furo[2,3-d]pyrimidine scaffold is conducive to dual human DHFR-TS inhibitory activity and to high potency and selectivity for pathogen DHFR.
机译:新型经典抗叶酸剂N- {4-[(2,4-二氨基-5-甲基-呋喃[2,3-d]嘧啶-6-基)硫代]-苯甲酰基} -1-谷氨酸5和11种非经典抗叶酸剂设计,合成和评估了6-16,作为二氢叶酸还原酶(DHFR)和胸苷酸合酶(TS)的抑制剂。通过使用碘氧化取代的苯硫酚由20合成非经典化合物6-16。中间体酸21的肽偶联,然后进行皂化,得到了经典的类似物5。据我们所知,化合物5是2,4-二氨基呋喃[2,3-d]嘧啶经典抗叶酸的第一个实例,该化合物具有针对人类DHFR和人类TS。与哺乳动物DHFR相比,经典类似物5是卡纳氏肺孢子虫DHFR和鸟分枝杆菌DHFR的纳摩尔抑制剂和显着选择性抑制剂,分别为263倍和2107倍。非经典类似物6-16对病原体DHFR或TS具有中等效力。这项研究表明,呋喃并[2,3-d]嘧啶骨架有利于双重人DHFR-TS抑制活性,并具有较高的效价和对病原体DHFR的选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号